Trial results suggest better use of existing drugs increases cervical cancer survival and reduces recurrence
The INTERLACE phase III trial assessed whether a short course of induction chemotherapy (IC) prior to chemoradiation (CRT) could reduce the rate of relapse and death among patients with locally advanced cervical cancer. As ...
Oct 22, 2023
0
0